488 related articles for article (PubMed ID: 22728642)
1. Nanotheranostics for personalized medicine.
Mura S; Couvreur P
Adv Drug Deliv Rev; 2012 Oct; 64(13):1394-416. PubMed ID: 22728642
[TBL] [Abstract][Full Text] [Related]
2. Theranostic nanomedicine.
Lammers T; Aime S; Hennink WE; Storm G; Kiessling F
Acc Chem Res; 2011 Oct; 44(10):1029-38. PubMed ID: 21545096
[TBL] [Abstract][Full Text] [Related]
3. Targeted nanotheranostics for personalized cancer therapy.
Diou O; Tsapis N; Fattal E
Expert Opin Drug Deliv; 2012 Dec; 9(12):1475-87. PubMed ID: 23092183
[TBL] [Abstract][Full Text] [Related]
4. Nanotheranostics and image-guided drug delivery: current concepts and future directions.
Lammers T; Kiessling F; Hennink WE; Storm G
Mol Pharm; 2010 Dec; 7(6):1899-912. PubMed ID: 20822168
[TBL] [Abstract][Full Text] [Related]
5. Supramolecular nanodevices: from design validation to theranostic nanomedicine.
Cabral H; Nishiyama N; Kataoka K
Acc Chem Res; 2011 Oct; 44(10):999-1008. PubMed ID: 21755933
[TBL] [Abstract][Full Text] [Related]
6. Nanomedicine for cancer: lipid-based nanostructures for drug delivery and monitoring.
Namiki Y; Fuchigami T; Tada N; Kawamura R; Matsunuma S; Kitamoto Y; Nakagawa M
Acc Chem Res; 2011 Oct; 44(10):1080-93. PubMed ID: 21786832
[TBL] [Abstract][Full Text] [Related]
7. Biomedical nanotechnology for cancer.
Pope-Harman A; Cheng MM; Robertson F; Sakamoto J; Ferrari M
Med Clin North Am; 2007 Sep; 91(5):899-927. PubMed ID: 17826110
[TBL] [Abstract][Full Text] [Related]
8. Nanomaterials for Nanotheranostics: Tuning Their Properties According to Disease Needs.
Wong XY; Sena-Torralba A; Álvarez-Diduk R; Muthoosamy K; Merkoçi A
ACS Nano; 2020 Mar; 14(3):2585-2627. PubMed ID: 32031781
[TBL] [Abstract][Full Text] [Related]
9. Perspectives and potential applications of nanomedicine in breast and prostate cancer.
Liu Y; Solomon M; Achilefu S
Med Res Rev; 2013 Jan; 33(1):3-32. PubMed ID: 23239045
[TBL] [Abstract][Full Text] [Related]
10. Personalized nanomedicine.
Lammers T; Rizzo LY; Storm G; Kiessling F
Clin Cancer Res; 2012 Sep; 18(18):4889-94. PubMed ID: 22829203
[TBL] [Abstract][Full Text] [Related]
11. Iron oxide-loaded nanotheranostics: major obstacles to in vivo studies and clinical translation.
Schleich N; Danhier F; Préat V
J Control Release; 2015 Jan; 198():35-54. PubMed ID: 25481448
[TBL] [Abstract][Full Text] [Related]
12. Emerging inorganic nanomaterials for pancreatic cancer diagnosis and treatment.
Yang F; Jin C; Subedi S; Lee CL; Wang Q; Jiang Y; Li J; Di Y; Fu D
Cancer Treat Rev; 2012 Oct; 38(6):566-79. PubMed ID: 22655679
[TBL] [Abstract][Full Text] [Related]
13. Nanotheranostics - application and further development of nanomedicine strategies for advanced theranostics.
Muthu MS; Leong DT; Mei L; Feng SS
Theranostics; 2014; 4(6):660-77. PubMed ID: 24723986
[TBL] [Abstract][Full Text] [Related]
14. Towards tailored management of malignant brain tumors with nanotheranostics.
Aparicio-Blanco J; Torres-Suárez AI
Acta Biomater; 2018 Jun; 73():52-63. PubMed ID: 29678675
[TBL] [Abstract][Full Text] [Related]
15. Nanotheranostics in evidence based personalized medicine.
Sharma S
Curr Drug Targets; 2014; 15(10):915-30. PubMed ID: 25174340
[TBL] [Abstract][Full Text] [Related]
16. Omics-based nanomedicine: the future of personalized oncology.
Rosenblum D; Peer D
Cancer Lett; 2014 Sep; 352(1):126-36. PubMed ID: 23941830
[TBL] [Abstract][Full Text] [Related]
17. Nanotheranostics: advanced nanomedicine for the integration of diagnosis and therapy.
Muthu MS; Mei L; Feng SS
Nanomedicine (Lond); 2014 Jul; 9(9):1277-80. PubMed ID: 25204816
[No Abstract] [Full Text] [Related]
18. Immunomicelles for advancing personalized therapy.
Sawant RR; Jhaveri AM; Torchilin VP
Adv Drug Deliv Rev; 2012 Oct; 64(13):1436-46. PubMed ID: 22917778
[TBL] [Abstract][Full Text] [Related]
19. Lipid- and polymer-based nanostructures for cancer theranostics.
Luk BT; Fang RH; Zhang L
Theranostics; 2012; 2(12):1117-26. PubMed ID: 23382770
[TBL] [Abstract][Full Text] [Related]
20. Nanomedicine and drug delivery.
Wei C; Wei W; Morris M; Kondo E; Gorbounov M; Tomalia DA
Med Clin North Am; 2007 Sep; 91(5):863-70. PubMed ID: 17826106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
